TITLE

THIOPURINES, BUT NOT CORTICOSTEROIDS OR 5-ASA, REDUCE THE NUMBER OF PLATELET-LEUCOCYTE AGGREGATES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

AUTHOR(S)
Irving, P.M.; Macey, M.G.; Shah, U.; Webb, L.; Langmead, F.L.; Rampton, D.S.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA64
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: We have previous]y shown that formation of platelet-leucocyte aggregates (PLAs) is increased in patients with IBD (UEGW 2000) and correlates with platelet activation (BSG 2001). Aims: To see if drugs commonly used to treat IBD affect PLA formation, platelet and neutrophil activation. Methods: Of 66 patients with IBD (31 Crohn's, 35 ulcerative colitis),17 patients were on thiopurines (11 azathioprine, 2 6-mercaptopurine), 17 prednisolone or hydrocortisone and 53 5-ASAs. Venous blood was drawn into F:DTA/CTAD anticoagulants. Samples were immediately mixed and then analysed by flow cytometry for P-selectin (CD62P for plate[et activation), L-selectin (CD62L for neutrophil activation) and CD42a/CD45 (plateletleucocyte aggregates). Results: Patients taking thiopurines had fewer PLAs (median (IQR)) (0.26 (0.20-0.38) × 10[sup 9]/L, n=17) than those that were not (0.37 (0.25-0.60), n=49, P<0.05). The number of platelets expressing P-selectin was similar in both groups (thiopurines 3.1 (1.4-6.0) × 109/L, no thiopurines 3.7 (1.9-8.7) × 10[sup 9]/L) as was expression of bselectin on neutrophils (thiopurines 802 (793-814), no thiopurines 792 (780-808)). There was no difference in any of these variables between patients taking and not taking corticosteroids or 5-ASAs. Conclusions: Thiopurines, but not corticosteroids or 5-ASAs, decrease the number of platelet-leucocyte aggregates in patients with BD; none of these agents appeared to affect platelet and neutrophil activation. It is conceivable that inhibition of platelet-leucocyte aggregate formation could contribute to the therapeutic efficacy of thiopurines in IBD.
ACCESSION #
9747723

 

Related Articles

  • METHODOLOGICAL STUDY TO ASSESS REPEAT PLANAR WHITE CELL SCANNING IN MONITORING THE EFFICACY OF TREATMENT IN INFLAMMATORY BOWEL DISEASE. Poullis, A.; Irwin, A.G.; Dearing, M.; Gane, J.; Britten, A.J.; Heenan, S.; Soni, P.; Vennart, W.; Maxwell, J.D. // Gut;Apr2003 Supplement 1, Vol. 52, pA87 

    Introduction: Radio-labelled white cell scans (WCS) provide non-invasive and accurate quantification of inflammatory bowel disease (IBD) activity in both large and small bowel and may be useful in the objective evaluation of treatments for IBD. Clinical activity scores are partly subjective and...

  • Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease. Arseneau, KO; Cominelli, F // Clinical Pharmacology & Therapeutics;Jan2015, Vol. 97 Issue 1, p22 

    Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammatory disease of the intestine that includes both Crohn's disease and ulcerative colitis, and afflicts nearly 1 million people throughout North America. As our understanding of IBD pathogenesis grows, several new therapies have...

  • Weakening link to colorectal cancer? Barbier, M.; Attoub, S.; Calvez, R.; Laffargue, M.; Jarry, A.; Mareel, M.; Altruda, F.; Gespach, C.; Wu, D.; Lu, B.; Hirsch, E.; Wymann, M.P. // Nature;10/25/2001, Vol. 413 Issue 6858, p796 

    Re-examines the enzyme phosphatidylinositol-3-OH kinase expression pattern reported by Sasaki et al and found that PI(3)Kgamma signals in colonic mucosa correlate with the presence of leukocytes. Strategy to fight chronic inflammatory disease; Undetectability of PI(3)Kgamma in normal colonic...

  • A DISTINCT SUBSET OF CHEMOKINES, INDUCED IN COLONIC EPITHELIUM BY IL-1β, DOMINATES THE MUCOSAL CHEMOKINE RESPONSE IN ULCERATIVE COLITIS. Puleston, J.; Cooper, M.; Murch, S.; Makh, S.; Ashwood, P.; Torrente, F.; Bingham, A.; Green, H.; Moss, P.; Dhillon, A.; Gelinas, R.; Pounder, R.; Platt, A. // Gut;Apr2003 Supplement 1, Vol. 52, pA59 

    Purpose: Inflammatory bowel disease (IBD) is characterised by intense mucosal recruitment of activated leukocytes. As chemokines determine inflammatory leukocyte recruitment and retention, we compared expression of the entire chemokine family within colonic mucosa from IBD patients and...

  • sulfasalazine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p721 

    An encyclopedia entry for "sulfasalazine" is presented. It is a disease-modifying antirheumatic drug that is also used to relieve intestinal inflammation in Crohn's disease and ulcerative colitis. Side effects of the drug include aplastic anaemia, and reduction in white blood cells and...

  • Brief reports.  // Formulary;Oct2002, Vol. 37 Issue 10, p502 

    Reports developments related to pharmaceuticals as of October 2002. Impact of smoking on patient with Crohn's disease who take munosuppressant inflixmab; Cardiovascular risk of long-term Depo-Provera use; Link between Depo-Provera and diminished vessel function.

  • Preface. Nakajima, Shigemi // Current Pharmaceutical Design;Feb2003, Vol. 9 Issue 4, p1 

    Presents an overview of research articles on inflammatory bowel disease published in February 2003 issue of the 'Current Pharmaceutical Design' periodical. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on studies of pharmaceutical design.

  • 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Present, Daniel H.; Meltzer, Stephen J.; Krumholz, Michael P.; Wolke, Anita; Korelitz, Burton I.; Present, D H; Meltzer, S J; Krumholz, M P; Wolke, A; Korelitz, B I // Annals of Internal Medicine;10/15/89, Vol. 111 Issue 8, p641 

    We assess toxicity related to 6-mercaptopurine in the treatment of inflammatory bowel disease by reporting our experience with 396 patients (120 patients with ulcerative colitis, 276 with Crohn disease) observed over 18 years. Follow-up data for a mean period of 60.3 months were obtained for 90%...

  • Leukocyte Migration in Acute Colonic Inflammatory Bowel Disease: Comparison of Histological Assessment and Tc-99m- HMPAO Labeled Leukocyte Scan. Ståhlberg, Dagny; Veress, Bèla; Måre, Klas; Granqvist, Staffan; Ågren, Brita; Richter, Sven; Löfgerg, Robert // American Journal of Gastroenterology;Feb1997, Vol. 92 Issue 2, p283 

    Noninvasive leukocyte scintigraphy for assessment of localization, extent, and degree of active inflammation in acute colonic inflammatory bowel disease have been shown to correlate well with endoscopy. This study compared findings of mucosal leukocyte migration assessed histologically with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics